Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q3 2025 Earnings Call Transcript November 5, 2025
Pacific Biosciences of California, Inc. beats earnings expectations. Reported EPS is $-0.12631, expectations were $-0.16.
Operator: Good day, and welcome to the PacBio Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Carrie Mendivil with Investor Relations. Please go ahead.
Carrie...
